Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Sun Pharma logs second-straight month of gains

** Shares of Sun Pharmaceutical Industries SUN.NS gains ~1.1% in March, marking second straight month of gains

** Stock among four Nifty 50 .NSEI constituents to log a monthly gain in a weak broader market

** Analysts expect the pharma co to benefit from the launch of weight-loss drugs in India

** UBS estimates generic GLP-1 market opportunity to reach $7.6 billion by 2030 for Indian pharma companies and says co is best placed to capture this long-term opportunity

** Stock rated "buy" on avg; median PT 1,978 rupees - data compiled by LSEG

** Stock up 2.1% YTD, closes 2% lower on Monday

nifty50 https://tmsnrt.rs/4sCF4jF

 (Reporting by Aleef Jahan in Bengaluru)

 ((aleefjahan.cs@thomsonreuters.com))

Recent news on Sun Pharmaceutical Industries

See all news